News

Common Sense PBM Reforms Are Needed Now to Make Medicines More Affordable FOR IMMEDIATE RELEASE August 10, 2022 Washington, DC – Mark...

Failure to include a monthly $35 insulin cap in the climate and health care bill that passed the Senate last weekend could especially...

It’s commonly known that the cost of prescription drugs in the U.S. has been rising well above inflation, 7.5% in some cases. Ironically...

Last week, Senate Majority Leader Chuck Schumer and Pesky 49th Vote Joe Manchin announced they’d reached a deal on a budget...

Prices are on the rise on just about every category of goods and services: food, housing, and healthcare. Consumers could use a break....

Two former Trump administration officials have taken to the Wall Street Journal to defend the practices of pharmacy benefit managers, the...

Prescription-drug prices are actually falling if you strip out the massive and growing rebates that pharmaceutical companies must pay to...

Democrats may be closer than ever to passing sweeping drug pricing reforms, but Sen. Ron Wyden says there’s more to do. During a STAT...

Congress should prioritize affordability of medicines needed by Medicare beneficiaries suffering from diabetes and other chronic...

Rising health care costs continue to put treatment out of reach for vulnerable communities in San Diego and across California, including...

Last month, the Federal Trade Commission (FTC) voted unanimously (5-0) to examine rising list prices of insulin, but also to probe...

hese are not comfortable days in Washington for pharmacy benefit managers, the highly consolidated group of intermediaries that sit...

The top leadership of CVS Health directed an illegal scheme to work across the corporation’s sprawling subsidiaries to drive up drug...

According to a 2021 Gallup poll, an estimated 18 million Americans can’t afford to pay for their much-needed prescription drugs. Across...

Top senators unveiled a bipartisan bill Wednesday that aims to curb the high cost of insulin, a lifesaving drug that some Americans have...

Legislation aimed at curbing several pharmacy benefit manager practices such as spread pricing cleared a key obstacle to passage in the...

Pressure is increasing on pharmacy benefit managers as the middlemen come under rising scrutiny from Washington for their role in rising...

The Federal Trade Commission voted unanimously yesterday (5-0) to adopt a new policy specifically targeting rising insulin prices, but...

The recent decision by the Federal Trade Commission to study the business practices of pharmacy benefit managers (PBMs) is a significant...

In a notable move, the Federal Trade Commission put drugmakers and pharmacy benefit managers on notice that the agency will “ramp up...

NCL is deeply concerned by the lack of transparency and accountability surrounding pharmacy benefit managers (PBMs). The pervasive power...

Centene will pay $13.7 million to settle more pharmacy benefit management overpayment allegations in Medicaid, this time in New Mexico....

Nobody wants fraud — particularly not in medical care. Accordingly, in 1972, Congress passed the Federal Anti-kickback Statute that...

The U.S. Federal Trade Commission has opened a probe into how big pharmacy benefit managers like CVS Caremark affect pricing and...